YMRC
ARKG icon

Yorktown Management & Research Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Yorktown Management & Research Company’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,500
Closed -$222K – 244
2021
Q1 		$222K Buy
+2,500
New +$248K 0.18% 225

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Yorktown Management & Research Company's ARKG Position: Q2 2021 in Review

Yorktown Management & Research Company sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 2,500 shares — an estimated $222K sold.

Yorktown Management & Research Company first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $222K in Q1 2021. 513 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Yorktown Management & Research Company reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,500 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $222K.
  • Yorktown Management & Research Company first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Yorktown Management & Research Company's ARK Genomic Revolution ETF position peaked at $222K in Q1 2021.
  • 513 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Yorktown Management & Research Company's 13F filing for Q2 2021, filed 3 Aug 2021.